Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.60 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.60 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.60 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.57 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.57 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.57 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.57 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10672729 | 0.90 | GABRA1 (0.61) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL10659542 | 0.89 | GABRA1 (0.60) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL6649418 | 0.89 | GABRA1 (0.60) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL10656205 | 0.89 | GABRA1 (0.73) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL10680370 | 0.87 | GABRA1 (0.58) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL10675841 | 0.86 | GABRA1 (0.58) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL7487639 | 0.85 | GABRA1 (0.67) | GABRA1GABRA6GABRB2GABRA3 | |
| SCHEMBL10368104 | 0.84 | GABRA1 (0.60) | GABRA1GABRA6GABRB2GABRA3 | |
| SCHEMBL10375644 | 0.84 | GABRA1 (0.55) | GABRA1GABRA6GABRB2GABRA3GABRG2 | |
| SCHEMBL9376708 | 0.84 | GABRA1 (0.49) | GABRA1GABRA6GABRA3GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4622320-A | CENTRAL NERVOUS SYSTEM DISORDERS | AS FERROSAN (DK) | 1986-11-11 | — | — | US | claimed |
| EP-0888354-B1 | PROCESS FOR PRODUCING RADIOLABELLED BENZODIAZEPINE RECEPTOR AGENTS AND COMPOSITION CONTAINING THE SAME | MAP MEDICAL TECHNOLOGIES OY (FI) | 2002-06-12 | — | — | EP | disclosed |
| US-6015544-A | RADIOACTIVE COMPOUNDS WITH BROMINE OR IODINE | MAP MEDICAL TECHNOLOGIES OY (FI) | 2000-01-18 | — | — | US | disclosed |
| EP-0888354-A1 | PROCESS FOR PRODUCING RADIOLABELLED BENZODIAZEPINE RECEPTOR AGENTS AND COMPOSITION CONTAINING THE SAME | Map Medical Technologies Oy (FI) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034898-A1 | PROCESS FOR PRODUCING RADIOLABELLED BENZODIAZEPINE RECEPTOR AGENTS AND COMPOSITION CONTAINING THE SAME | MAP MEDICAL TECHNOLOGIES OY (FI) | 1997-09-25 | — | — | WO | disclosed |
| EP-0202441-B1 | OXADIAZOLYLIMIDAZOBENZODIAZEPINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | A/S FERROSAN (DK) | 1988-11-17 | — | — | EP | disclosed |
| EP-0202441-A1 | Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions | A/S FERROSAN (DK) | 1986-11-26 | — | — | EP | disclosed |
| US-4622320-A | CENTRAL NERVOUS SYSTEM DISORDERS | AS FERROSAN (DK) | 1986-11-11 | — | — | US | disclosed |